Program Description: 

This series is for clinicians, nurses, APPs to have a forum to discuss the management of complex lymphoma cases. During this we discuss appropriate management options, clinical trial availability, and recently published data that would guide our decision making. We review pathology, radiological images, and clinical course for each patient presented.

 Lymphoma, Treatment, Pathology, Leukemia

Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Pharmacists
  • Psychologists
  • Social Workers
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Manage various complex lymphoma cases
  • Utilize diagnostic and pathological tools utilized to characterize a lymphoma
  • Improve patient outcomes through group discussion
Faculty & credentials: 
Planning Committee:

Nirav Shah, MD (Activity Director)
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin

Sumana Devata, MD
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin

Timothy Fenske, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin

Mehdi Hamadani, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin

Walter Longo, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin

 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
  • Sumana Devata, MD
  • Walter Longo, MD

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

NameCompanyRole
Nirav Shah, MDLoxo-LillyConsultant, Researcher
 Miltenyi BiotecConsultant, Researcher
 EpizymeAdvisory Board
 Janssen Advisory Board
 Kite PharmaAdvisory Board
 IncyteAdvisory Board
 Seattle GeneticsAdvisory Board
 NovartisAdvisory Board
 BMS-JunoAdvisory Board
 TG TherapeuticsAdvisory Board
 UmojaAdvisory Board
 Tundra TherapeuticsAdvisory Board/Founder
Timothy Fenske, MDAstraZenecaConsultant/Speaker
 Kite PharmaceuticalsConsultant/Speaker
 BeigeneConsultant/Speaker
 AbbVieConsultant
 SeagenConsultant/Speaker
 Adaptive BiotechnologiesConsultant
 TG TherapeuticsSpeaker
 Lilly/LoxoConsultant
 ADC TherapeuticsConsultant
 Ono Pharmaceuticals Consultant
 MorphoSysConsultant/speaker
Mehdi Hamadani, MDADC TherapeuticsConsultant/Speaker/Researcher
 Spectrum PharmaceuticalsResearcher
 Astellas PharmaResearcher
 OmerosConsultant
 CRISPRConsultant/speaker
 BMSConsultant
 Kite PharmaceuticalsConsultant/speaker
 AbbvieConsultant
 GenmabConsultant
 AllovirConsultant
 CaribouConsultant
 AstraZenecaSpeaker
 BeiGeneSpeaker
 GenentechSpeaker
 Myeloid TherapeuticsSpeaker

Contact

Name: 
Brianna Just
Series date: 
01/01/2024 - 8:00am CST to 12/31/2024 - 11:59pm CST

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

MOC Part II:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
-10 MOC points in the American Board of Pathology (ABPath) Maintenance of Certification (MOC) program; and
-10 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.
 
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

 

Group description: 
Lymphoma Tumor Board Conference 2024
Series location: 
Virtual Meeting
Milwaukee, WI
United States

Sessions

Session Date
Lymphoma Tumor Board - February 02/12/2024 - 12:00pm to 1:00pm CST
Lymphoma Tumor Board - February 02/26/2024 - 12:00pm to 1:00pm CST
Lymphoma Tumor Board - March 03/11/2024 - 12:00pm to 1:00pm CDT
Lymphoma Tumor Board - March 03/25/2024 - 12:00pm to 1:00pm CDT
Lymphoma Tumor Board - April 04/08/2024 - 12:00pm to 1:00pm CDT
Lymphoma Tumor Board - April 04/22/2024 - 12:00pm to 1:00pm CDT
Lymphoma Tumor Board - May 05/13/2024 - 12:00pm to 1:00pm CDT
Lymphoma Tumor Board - May 05/27/2024 - 12:00pm to 1:00pm CDT